GAVILYTE-H AND BISACODYL- polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride and bisacodyl delayed-release tablet 
Lupin Pharmaceuticals, Inc.

----------

Medication Guide

GaviLyte - H (GAV-ee-LITE-H) and Bisacodyl (BIS-a-CO-dil)Delayed-Release Tablet, USP.

(PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablet, USP)

Read this Medication Guide before you start taking GaviLyte - H and bisacodyl delayed-release tablet, USP. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment.

What is the most important information I should know about GaviLyte - H and bisacodyldelayed-release tablet, USP?

GaviLyte - H and bisacodyl delayed-release tablet, USP and other osmotic bowel preparations can cause serious side effects, including: Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood. These changes can cause:

Your chance of having fluid loss and changes in body salts with GaviLyte - H and bisacodyl delayed-release tablet, USPis higher if you:

Tell your healthcare provider right away if you have any of these symptoms of a loss of too much body fluid (dehydration) while taking GaviLyte - H and bisacodyldelayed-release tablet, USP:

See “What are the possible side effects of GaviLyte - H and bisacodyl delayed-release tablet, USP?” for more information about side effects.

What is GaviLyte - H and bisacodyl delayed-release tablet, USP?

GaviLyte - H and bisacodyl delayed-release tablet, USP is a prescription medicine used by adults to clean the colon before a colonoscopy. GaviLyte - H and bisacodyl delayed-release tablet, USP cleans your colon by causing you to have diarrhea. Cleaning your colon helps your healthcare provider see the inside of your colon more clearly during your colonoscopy. It is not known if GaviLyte - H and bisacodyl delayed-release tablet, USP is safe and effective in children.

Who should not take GaviLyte - H and bisacodyldelayed-release tablet, USP?

Do not take GaviLyte - H and bisacodyl delayed-release tablet, USP if your healthcare provider has told you that you have:

What should I tell my healthcare provider before taking GaviLyte - H and bisacodyldelayed-release tablet, USP?

Before you take GaviLyte - H and bisacodyldelayed-release tablet, USP tell your healthcare provider if you:

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

GaviLyte - H and bisacodyl delayed-release tablet, USP may affect how other medicines work. Medicines taken by mouth may not be absorbed properly when taken within 1 hour before the start of GaviLyte - H and bisacodyl delayed-release tablet, USP.

Especially tell your healthcare provider if you take:

Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure if you are taking any of the medicines listed above. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take GaviLyte - H and bisacodyldelayed-release tablet, USP?

See the Patient Directions on the outer product carton for dosing instructions. You must read, understand, and follow these instructions to take GaviLyte - H and bisacodyldelayed-release tablet, USPthe right way.

What are the possible side effects of GaviLyte - H and bisacodyldelayed-release tablet, USP?

GaviLyte - H and bisacodyl delayed-release tablet, USP can cause serious side effects, including:

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of GaviLyte - H and bisacodyl delayed-release tablet, USP. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store GaviLyte - H and bisacodyldelayed-release tablet, USP?

Keep GaviLyte - H and bisacodyldelayed-release tablet, USP and all medicines out of the reach of children.

General information about the safe and effective use of GaviLyte - H and bisacodyldelayed-release tablet, USP.

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use GaviLyte - H and bisacodyl delayed-release tablet, USP for a condition for which it was not prescribed. Do not give GaviLyte - H and bisacodyl delayed-release tablet, USP to other people, even if they are going to have the same procedure you are. It may harm them.

This Medication Guide summarizes the most important information about GaviLyte - H and bisacodyl delayed-release tablet, USP. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information that is written for healthcare professionals.

What are the ingredients in GaviLyte - H and bisacodyldelayed-release tablet, USP?

Active ingredients bisacodyl tablet: bisacodyl.

Inactive ingredients bisacodyl tablet: lactose (anhydrous) NF, microcrystalline cellulose NF, croscarmellose sodium NF, magnesium stearate NF, methacrylic acid copolymer, talc, titanium dioxide, triethyl citrate, D&C red # 27/phloxine aluminum lake, colloidal anhydrous silica, sodium bicarbonate, sodium lauryl sulfate, FD&C blue # 2/indigo carmine aluminum lake and FD&C yellow # 6/sunset yellow FCF aluminum lake.

Active ingredients GaviLyte - H: polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride.

Inactive ingredients GaviLyte - H: cherry, lemon, and orange flavor packs.

Manufactured by:

Novel Laboratories, Inc.
Somerset, NJ 08873

Manufactured for:

GAVIS Pharmaceuticals LLC

Somerset, NJ 08873

This Medication Guide has been approved by the U.S. Food and Drug Administration.

PI0701700201
Iss. 12/2014

Revised: 1/2020
Lupin Pharmaceuticals, Inc.